- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 4, Issue 127, Pages 127rv3-127rv3
Publisher
American Association for the Advancement of Science (AAAS)
Online
2012-03-29
DOI
10.1126/scitranslmed.3003180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applying What We Know to Accelerate Cancer Prevention
- (2012) G. A. Colditz et al. Science Translational Medicine
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- MRI of the prostate: Clinical relevance and emerging applications
- (2011) Yousef Mazaheri et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
- (2011) John R Prensner et al. NATURE BIOTECHNOLOGY
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- Predictive biomarkers: a paradigm shift towards personalized cancer medicine
- (2011) Nicholas B. La Thangue et al. Nature Reviews Clinical Oncology
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer
- (2011) G. Tavoosidana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advancements in MR Imaging of the Prostate: From Diagnosis to Interventions
- (2011) David Bonekamp et al. RADIOGRAPHICS
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
- (2011) S. A. Tomlins et al. Science Translational Medicine
- Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling
- (2010) Ayman S. Moussa et al. BJU INTERNATIONAL
- American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
- (2010) A. M. D. Wolf et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
- (2010) Monique J. Roobol et al. EUROPEAN UROLOGY
- Exosomes as Biomarker Treasure Chests for Prostate Cancer
- (2010) Diederick Duijvesz et al. EUROPEAN UROLOGY
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- Cancer Biomarkers: Can We Turn Recent Failures into Success?
- (2010) E. P. Diamandis JNCI-Journal of the National Cancer Institute
- Overdiagnosis in Cancer
- (2010) H. G. Welch et al. JNCI-Journal of the National Cancer Institute
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Breast cancer assessment tools and optimizing adjuvant therapy
- (2010) Catherine Oakman et al. Nature Reviews Clinical Oncology
- Comparative Effectiveness and Health Care Spending — Implications for Reform
- (2010) Milton C. Weinstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of genome-wide and replication association studies on prostate cancer
- (2010) Hong Liu et al. PROSTATE
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- False-negative Prostate Needle Biopsies: Frequency, Histopathologic Features, and Follow-up
- (2009) Tineke Wolters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
- (2009) J Nilsson et al. BRITISH JOURNAL OF CANCER
- Rational approach to implementation of prostate cancer antigen 3 into clinical care
- (2009) Rou Wang et al. CANCER
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
- (2009) Anuradha Gopalan et al. CANCER RESEARCH
- Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling
- (2009) L. Zhao et al. CANCER RESEARCH
- Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
- (2009) G. Attard et al. CANCER RESEARCH
- Oncogenic gene fusions in epithelial carcinomas
- (2009) John R Prensner et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease–Induced Congestive Heart Failure or Myocardial Infarction
- (2009) Akash Nanda JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rethinking Screening for Breast Cancer and Prostate Cancer
- (2009) Laura Esserman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
- (2009) Kanishka Sircar et al. JOURNAL OF PATHOLOGY
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Predicting Prostate Cancer Biochemical Recurrence Using a Panel of Serum Proteomic Biomarkers
- (2009) C. Nicole Rosenzweig et al. JOURNAL OF UROLOGY
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- The use of PCA3 in the diagnosis of prostate cancer
- (2009) Daphne Hessels et al. Nature Reviews Urology
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening Test
- (2009) Pamela A. Shaw et al. Statistics in Biopharmaceutical Research
- Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research
- (2008) R. O. Barnes et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
- (2008) M. S. Lucia et al. Cancer Prevention Research
- A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
- (2008) B. Laxman et al. CANCER RESEARCH
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
- (2008) G. Sardana et al. CLINICAL CHEMISTRY
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
- Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population
- (2008) David Ulmert et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomic Analysis of Conditioned Media from the PC3, LNCaP, and 22Rv1 Prostate Cancer Cell Lines: Discovery and Validation of Candidate Prostate Cancer Biomarkers
- (2008) Girish Sardana et al. JOURNAL OF PROTEOME RESEARCH
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
- (2008) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
- The cancer biomarker problem
- (2008) Charles L. Sawyers NATURE
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
- (2008) Martin G. Sanda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Detection of Prostate Cancer in 2007
- (2007) Fritz H. Schröder et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer
- (2007) Axel Heidenreich et al. EUROPEAN UROLOGY
- The Natural History of Men Treated With Deferred Androgen Deprivation Therapy in Whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy
- (2007) Danil V. Makarov et al. JOURNAL OF UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now